RiverVest Venture Management LLC Current Holdings: USA Other Stocks

RiverVest Venture Management LLC current holdings: USA Other Stocks

RiverVest Venture Management LLC reported $0.01 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 3 positions, in its Form 13F for the quarter ended 2024-09-30; the largest are Reneo Pharmaceuticals, Inc., Spruce Bioscience, Inc., Xilio Therapeutics, Inc..

Reneo Pharmaceuticals, Inc.: Country of operation United States; Class Common; Shares 2,534,220; Value $4,308,174.
Spruce Bioscience, Inc.: Country of operation United States; Class Common; Shares 2,936,281; Value $1,394,441.
Xilio Therapeutics, Inc.: Country of operation United States; Class Common; Shares 1,441,444; Value $1,135,425.

Form 13F-HR as filed (SEC CIK 1812549): quarter ended 2024-09-30, filed 2024-10-30. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Stock	Country of operation	Class	Shares	Value	Quarter end	Filed
Reneo Pharmaceuticals, Inc. CUSIP 75974E103	United States	Common	2,534,220	$4,308,174	2024-09-30	2024-10-30
Spruce Bioscience, Inc. CUSIP 85209E109	United States	Common	2,936,281	$1,394,441	2024-09-30	2024-10-30
Xilio Therapeutics, Inc. CUSIP 98422T100	United States	Common	1,441,444	$1,135,425	2024-09-30	2024-10-30

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet